Search results for: OHE Consulting
Filter search results
Biosimilars: Modelling the Evolution of the Market
16 June 2010
The OHE model varies from other models of biosimilar markets evolution by starting with transaction prices, rather than list prices, and factoring in the collection of ‘Patient Safety Year’ (PSY)…
OHE’s submission to Belgium’s Committee on Health and Equal Opportunities argues value-based pricing delivers a ‘triple-win’
18 December 2024
Professor Graham Cookson, OHE’s Chief Executive, was invited to respond to two draft bills on drug pricing discussed in the Committee on Health and Equal Opportunities of the Belgian House of…
OHE at IHEA 2023
9 July 2023, 7:00am
Full OHE schedule for IHEA: Name Date of Session Time of Session Title of session Session Location Graham Cookson and Amanda Cole 09/07/2023 14:00-16:00 SAST/13:00-15:00 BST Anticipating the Potential Impacts…
Access to Orphan Drugs in the EU
21 October 2010
Legislation in the EU provides incentives for the developmeng of drugs for rare diseases, known as orphan medicinal products (OMPs). At a recent conference, OHE’s Dr Mestre-Ferrandiz reported on OHE…
Invitation to OHE’s Annual Lecture 2017: Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe?
12 May 2017
OHE’s annual lecture 2017 will be held on Thursday 15 June at the Royal Society, London. The lecture will be given by Professors Anne Case and Sir Angus Deaton on…
OHE at HESG Winter 2021
11 January 2021
Members from the team at OHE attended the Health Economists’ Study Group (HESG) Winter 2021 Meeting, hosted online by the Centre for Health Economics in London, LSHTM, from 6th-8th January…
OHE is Moving its Offices
23 May 2011
On 31 May, OHE will be moving its offices to Southside, 7th Floor, 105 Victoria Street, London SW1E 6QT. Telephone/fax numbers and e-mails will remain the same. We look forward…
How Important are the Differences Between the EQ-5D-5L and EQ-5D-3L Value Sets?
24 March 2017
…sets differ? And how important are these differences likely to be for users? A new OHE Research Paper by Mulhern et al. (2017) compares the characteristics of the value sets….
Antibacterials: Roundtable Addresses the Critical Issues
10 November 2011
…investment in R&D. OHE has been very involved in both defining the challenge and thinking through possible responses. Antibacterial drug resistance is a serious and growing worldwide problem that threatens…